Showing results (701-710 of 1,321) with videos related to

Sort By:
Pageof 133
Neurology|November 18, 1998
Defective peroxisome biogenesis with a neuromuscular disorder resembling Werdnig-Hoffmann diseaseM R Baumgartner, N M Verhoeven, C Jakobs, et al.
Scandinavian Journal of Gastroenterology|March 21, 2015
Low interobserver agreement among endoscopists in differentiating dysplastic from non-dysplastic lesions during inflammatory bowel disease colitis surveillanceLinda K Wanders, Erik Mooiweer, Junfeng Wang, et al.
Journal of Inherited Metabolic Disease|June 10, 2006
Potential of fibrates in the treatment of fatty acid oxidation disorders: revival of classical drugs?F Djouadi, F Aubey, D Schlemmer, et al.
Clinical Science (London, England : 1979)|October 24, 2008
Muscle acylcarnitines during short-term fasting in lean healthy menMaarten R Soeters, Hans P Sauerwein, Marinus Duran, et al.
Leukemia Research|August 19, 2008
TP53 mutations predict for poor survival in de novo diffuse large B-cell lymphoma of germinal center subtypeNorafiza Zainuddin, Mattias Berglund, Alkwin Wanders, et al.
British Journal of Cancer|August 1, 1994
Docetaxel (Taxotere) in advanced gastric cancer: results of a phase II clinical trial. EORTC Early Clinical Trials GroupA Sulkes, J Smyth, C Sessa, et al.
Biochimica Et Biophysica Acta|March 19, 1987
Catalase in cultured skin fibroblasts from patients with the cerebro-hepato-renal (Zellweger) syndrome: normal maturation in peroxisome-deficient cellsR J Wanders, A Strijland, C W van Roermund, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|March 21, 1998
Warm flush at 37 degrees C following cold storage attenuates reperfusion injury in preserved rat liversB A van Wagensveld, M E Reinders, T M van Gulik, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Zeniplatin in advanced malignant melanoma and renal cancer: phase II studies with unexpected nephrotoxicityS Aamdal, U Bruntsch, J Kerger, et al.
European Journal of Clinical Investigation|March 18, 2004
Changes in blood carnitine and acylcarnitine profiles of very long-chain acyl-CoA dehydrogenase-deficient mice subjected to stressU Spiekerkoetter, C Tokunaga, U Wendel, et al.
Pageof 133